Delivery Order SPE2DB22D3301-SPE2DB25FX4UG
Award Date
10/31/24
Potential Completion Date
11/1/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,496.44, is for the delivery of Mesalamine DR 1.2 GM Tablets. This appears to be a firm fixed-price delivery order contract with a completion date of January 15, 2025. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablet 120S. The $1,541.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, with ID SPE2DB24D2212|SPE2DB25FHPPD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Mesalamine DR 1.2 GM Tablet 120S, a pharmaceutical product, with a ceiling value of $1,594.32 and a period of performance through April 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.47 fixed-price delivery order is for the supply of 4,565,481,647 units of the medication Mesalamine DR 1.2 GM Tablet, with a performance period ending on August 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,368.24, is for the delivery of 120 units of Mesalamine DR 1.2 GM Tablets. This is a firm fixed-price delivery order contract with a completion date of May 5, 2023. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,826.70 firm fixed-price delivery order is for 4,562,867,891 units of the prescription drug Mesalamine DR 1.2 GM Tablet, with a completion date of November 21, 2023. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP1SW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120s, with a total ceiling value of $10,090.83. It is a firm-fixed-price delivery order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.32 firm fixed-price delivery order is for the supply of 120 tablets of the drug Mesalamine DR 1.2 GM. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUYE2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,943,595 tablets of the medication Mesalamine DR 1.2 GM. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,247.15 and an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,181.45 for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of June 4, 2024 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC)...